Ivermectin or Molnupiravir For Treating And Killing Covid In Covid Cases Now
There are still many nations where vaccines are not yet widely available,
There is a gradual shift in focus, to antiviral drugs,
Adjunctive chemoprophylaxis
Active treatment of new SARS-CoV-2 infections
Post -vaccination breakthrough COVID-19 cases
The two ways to get new drugs
Develop novel antiviral drugs for SARS-CoV-2
Repurpose existing FDA -approved drugs to treat COVID-19
Ivermectin is the most studied “repurposed” medication globally,
in randomized clinical trials, retrospective studies and meta- analyses.
Molnupiravir and Ivermectin Anti-SARS- CoV-2 Mechanisms, Pharmacokinetics and Pharmacodynamics
Molnupiravir is a broad spectrum antiviral agent against SARS- CoV-2, SARS-CoV,
seasonal or pandemic influenza and MERS corona virus
Ivermectin is an FDA-approved, WHO essential drug used as broad spectrum antiparasitic, antibiotic
and which has demonstrated broad spectrum antiviral activity against RNA viruses, including HIV, Zika, MERS corona virus
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
https://www.sciencedirect.com/science...
5000-fold inhibition of SARS-CoV-2, (99.98% at 48 hours
The inhibitory concentration IC50 of Molnupiravir shows it to be a more potent anti-SARS-CoV-2 agent, compared to Ivermectin in vitro.
Both molnupiravir and ivermectin are well absorbed after oral dosing
Tmax of molnupiravir being 1-1.75 hours,
With a half life of 7 hours
Tmax of ivermectin is 4-6 hours
Very long half life of 81-91 hours
Ivermectin, being lipophilic has a large volume of distribution
Ivermectin has the ability to accumulate in the lungs
The anti-SARS-CoV-2 actions, both of molnupiravir and ivermectin, are dose and concentration dependent
Molnupiravir active metabolite (NHC-5’ Triphosphate), acts as a competitive alternative substrate for viral RNA
causing viral mutagenesis or mutations, which leads to viral error catastrophe and extinction of replication
There is some concern about the safety of NHC -nucleoside triphosphate, which is also mutagenic to mammalian cells
Ivermectin, multifarious actions,
Binding to SARS-CoV-2 spike protein S
Reducing cell entry via human ACE2 receptors
Reducing viral transcription
Inhibition of cytokine production and inflammation
(not yet been shown for molnupiravir)
Complimentary pharmacokinetics and pharmacodynamics of the drugs
May be additive or synergistic
This should be further investigated in anti-SARS- CoV-2 antiviral combination therapy.
A combination of molnupiravir with Ivermectin putatively, in effects on RdRP or cytokine release.
Cost
-
2:32
KJRH
2 years agoOSDH: COVID cases, vaccinations rising
1764 -
2:19
WMAR
2 years agoCOVID cases are surging nationwide
3382 -
9:28
MichaelBisping
19 hours agoBISPING: "Conor McGregor Looks REALLY SHARP!" | DROPS SPARRING PARTNER | TRAINING FOOTAGE BREAKDOWN
17.4K31 -
15:56
Melonie Mac
15 hours agoXbox Showcase Uglifies the Women
46K117 -
2:32:51
Price of Reason
16 hours agoThe Acolyte Episode 3 Reaction, Disney Star Wars Biggest FAIL? Xbox Games PUSH DEI w/ Dreadroberts
41.1K4 -
36:13
Candace Owens
12 hours agoThe REAL Reason My Show Was Canceled | Candace Show Ep 2
59.7K256 -
1:39:43
Winston Marshall
6 days ago"United Nations And Hamas Are In Bed Together" Melanie Phillips | The Winston Marshall Show #017
58K56 -
21:14
Stephen Gardner
18 hours ago🔴BREAKING: Hunter Biden Convicted | Joe Biden a TOTAL MESS Privately | Trump dominates!!
38K42 -
2:53:58
Jerry After Dark
17 hours agoJerry After Dark: Ping Pong Trickshots
75.2K16 -
4:47:54
SNEAKO
18 hours agoSNEAKO X BELAL MUHAMMAD X LAUREN CHEN
119K43